Intas Pharma Ltd. (Amalgamated) (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Intas Pharma(Amalgam

Based on:

M-Cap below 100cr DeciZen not available

Intas Pharma Ltd. (Amalgamated) (Amalgamated) stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Intas Pharma(Amalgam:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12TTM
ROCE % 0%-17.9%5.7%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 04.669.870
Sales YoY Gr.-NA1,416.5%-
Adj EPS 0-38.2-1.90
YoY Gr.-NANA-
BVPS (₹) -8.127.243.50
Adj Net
Profit
0-38.2-2.90
Cash Flow from Ops. 8.3-17.8-74.1-
Debt/CF from Ops. 15-6.9-2.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA1416.5%
Adj EPS NANANANA
BVPSNANANA59.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12TTM
Return on
Equity %
0-182.1-6.30
Op. Profit
Mgn %
0-402.320.4NAN
Net Profit
Mgn %
0-829.9-4.10
Debt to
Equity
-314.52.5-
Working Cap
Days
01,6044470
Cash Conv.
Cycle
01,0721770

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Intas Pharma Ltd. (Amalgamated) (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 69.8 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 50 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 40.2

Management X-Ray of Intas Pharma(Amalgam:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Intas Pharma(Amalgam - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Intas Pharma(Amalgam

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12
Sales04.6069.75
Operating Expenses 023.3955.55
Manufacturing Costs06.578.68
Material Costs08.6532.98
Employee Cost 04.195.87
Other Costs 03.998.02
Operating Profit 0-18.7914.20
Operating Profit Margin (%) --408.0%20.4%
Other Income 00.593.31
Interest 013.878.49
Depreciation 05.906.80
Exceptional Items 000
Profit Before Tax 0-37.972.22
Tax 00.083.28
Profit After Tax 0-38.06-1.06
PAT Margin (%) --827.0%-1.5%
Adjusted EPS (₹)0.0-38.1-0.7
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12

Equity and Liabilities

Shareholders Fund 14.7527.1965.23
Share Capital 4.951015
Reserves 9.8017.1950.23
Minority Interest000
Debt124.53110.78148.55
Long Term Debt124.53110.78131.93
Short Term Debt0016.62
Trade Payables10.9134.3350.34
Others Liabilities 1.3713.2428.85
Total Liabilities 151.56185.55292.97

Fixed Assets

Gross Block0159.39166.26
Accumulated Depreciation05.8412.62
Net Fixed Assets 0153.55153.64
CWIP 124.1000
Investments 000
Inventories4.1122.6257.25
Trade Receivables06.1974.47
Cash Equivalents 0.080.170.14
Others Assets 23.273.027.47
Total Assets 151.56185.55292.97

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12
Cash Flow From Operating Activity 8.28-17.82-74.05
PBT 0-37.972.22
Adjustment 020.0515.35
Changes in Working Capital 8.130.1-91.62
Tax Paid 0.1500
Cash Flow From Investing Activity -108.48-16.86-6.95
Capex -108.48-16.86-6.95
Net Investments 000
Others 0-00
Cash Flow From Financing Activity 77.7134.5480.97
Net Proceeds from Shares 050.5050
Net Proceeds from Borrowing 77.7100
Interest Paid 0-13.87-8.49
Dividend Paid 000
Others 0-2.1039.46
Net Cash Flow -22.49-0.15-0.03

Finance Ratio

PARTICULARSMar'10Mar'11Mar'12
Ratios
ROE (%)0-328.42-2.3
ROCE (%)0-17.855.68
Asset Turnover Ratio00.030.29
PAT to CFO Conversion(x)N/AN/AN/A
Working Capital Days
Receivable Days0491211
Inventory Days01,060209
Payable Days0954468

Intas Pharma Ltd. (Amalgamated) (Amalgamated) Stock News

Intas Pharma Ltd. (Amalgamated) (Amalgamated) FAQs

The current trading price of Intas Pharma(Amalgam on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Intas Pharma(Amalgam stood at ₹0.00.
The latest P/E ratio of Intas Pharma(Amalgam as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Intas Pharma(Amalgam as of 31-Dec-1969 is 0.00.
The 52-week high of Intas Pharma(Amalgam is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Intas Pharma(Amalgam is ₹69.75 ( Cr.) .

About Intas Pharma Ltd. (Amalgamated) (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×